You searched for "elective"

1426 results found

Scottish Glaucoma Symposium 2024

by Nivi Aravind, Y5 Medical Student, University of Edinburgh, UK. The 22nd Scottish Glaucoma Symposium enlivened the prestigious Royal College of Surgeons in Edinburgh on 21 June in what was a delightful meeting of minds. The day’s programme was impeccably...

Eye News to host educational day focused on AI and new technology

We’re delighted to announce that we will be hosting a symposium again next year as part of Eyecare 2020.

One muscle surgery

This is a review of current literature on unilateral strabismus surgery for small to moderate angle esotropia, exotropia, residual and consecutive strabismus and convergence or divergence insufficiency. The review considers recession surgery for eso / exotropia of angles up to...

BT for cyclic esotropia

This paper describes two patients with childhood cyclic esotropia treated with botulinum toxin (BT) and followed for eight and nine years. Onset was at two and four years of age. BT was injected under electromyography (EMG) guidance bilaterally to medial...

Reducing myopia progression

This paper reports a literature review to discuss the environmental considerations and treatment options that can prevent the progression of myopia, including time spent outdoors, reduction of near vision activities, spectacle types, contact lens type and pharmacological treatment. The review...

Single muscle surgery for hypertropia

The authors undertook partial tenotomies combined with graded marginal recession of single vertical rectus muscles to treat small angle hypertropia in four adults with fusion potential. They report dose response, surgical technique and outcomes. Dose response closely matched the theoretical...

Licence to save: a UK survey of anti-VEGF use for the eye

This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...

‘Agenda-setting’ BCLA Clinical Conference to shape the future of contact lens practice around the world

The global eye care professional network’s “unquenchable thirst for learning” ensured the success of the first in-person BCLA Clinical Conference & Exhibition in four years.

Binocular single vision (BSV)

Introduction In this article I will try to summarise some of the definitions, tests and assessments performed in the strabismus clinic to assess patient binocular potential. This is a key feature of strabismus assessment, especially in adults, and it will...

Late stromal rejection in DALK

This case series reported on late stromal rejections in eyes after uncomplicated deep anterior lamellar keratoplasties (DALKs). Four eyes of three patients experienced episodes of isolated stromal rejection 33 to 46 months after surgically uncomplicated DALKs and a minimum of...

Four year outcomes of macular degeneration treated with ranibizumab

The authors report on a retrospective study of neovascular age-related macular degeneration (AMD) patients treated with a variable ranibizumab dosing regimen over a period of four years (from January 2007 to December 2011). A total of 600 treatment naïve eyes...

Corneal crosslinking in pellucid marginal degeneration

Fourteen studies were included in this first review examining the use of corneal-crosslinking (CXL) to treat pellucid marginal degeneration (PMD). PMD is a bilateral, non-inflammatory corneal thinning disorder characterised by inferior peripheral corneal thinning 1-3mm from the limbus in the...